Antibiotic resistance: who will pay the bills?

Editorial

Theoklis E Zaoutis. Clin Infect Dis. 2009.

. 2009 Oct 15;49(8):1185-6.

doi: 10.1086/605631.

No abstract available

Conflict of interest statement

The author declares that he has no potential conflicts of interest to disclose.

Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.
Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Roberts RR, et al. Clin Infect Dis. 2009 Oct 15;49(8):1175-84. doi: 10.1086/605630. Clin Infect Dis. 2009. PMID: 19739972

1. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis. 1987 Nov–Dec;9(6):1065–1078. - PubMed
1. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther. 2008 Oct;6(5):751–763. - PubMed
1. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003 Jun 1;36(11):1433–1437. - PubMed
1. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82–S89. - PubMed
1. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003 Jan 15;36 Suppl 1:S11–S23. - PubMed